Oskotec CEO Taeyoung Yoon Receives KSMC Innovation Award
Recognized for Achievements in First-in-Class Drug Development and Technology Transfer
OSKOTEC announced on September 30 that CEO Taeyoung Yoon will receive the “Innovation Award” from the Korean Society of Medicinal Chemistry (KSMC) on October 1. The awards ceremony will take place at the 2nd Regular KSMC Academic Conference, held in Cheongju, Osco.
The KSMC Innovation Award is presented to researchers in medicinal chemistry who have contributed to the development of the industry through technological innovation and product development in the field of new drug discovery. CEO Yoon was recognized for establishing the foundation for first-in-class innovative drug research and development in Korea and successfully translating these achievements into technology transfer deals.
Hot Picks Today
Where Have All the 'Finished Today's Workout' MZs Gone?... 6 Out of 10 Men in Their 30s Are Obese
- "Eat and Play All Day for Just 20,000 Won"... Rise of 'Chinese Gatherings' Spreading by Word of Mouth
- For Every Unit Sold in Korea, Nine Go Overseas... Tucson Surpasses 10.6 Million in Global Sales, Growth Continues
- Cracked Underground Parking Lot... Residents Protest: "4-Meter Giant Piles Damage Apartment Foundation"
OSKOTEC has continued to deliver business results this year, including the technology export of Cevidoplenib to Agios, the signing of a global exclusive technology transfer option contract for Denpivontinib, and the technology transfer of ADEL-Y01 to Sanofi.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.
!["Failed Even With Net Assets of 400 Million Won?"... Six Criteria That Define 'The Real Middle Class' [Data Pick]](https://cwcontent.asiae.co.kr/asiaresize/307/2026092809144741876_1790554486.jpg)
